#acr22 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #acr22, aggregated by home.social.
-
-
Daltroy Lecture 2022 Links
Daltroy Lecture 2022 #acr22
Life Hacks in Rheumatic Disease: Lessons Learned from TikTok and Social Media - Lecture Handout -
.@[email protected] brings in #ACR22 abs 0905 from @[email protected] @[email protected]
use of #MachineLearning to predict RA dz activity (CDAI) at next visit in #RISE
-
Doing #ACR22 review (our second one so far) in @[email protected] research meeting and discussing abs 1809 using CARES trial data. Work from @[email protected] @[email protected]
-
#ACR22 Immunology boot camp 2. Cytotoxic therapy is pretty downstream. -mod meds are migration inhibitors
-
-
Alternate-day GC use for IgG4-RD vs daily GC. More IS use with alternate-day. No difference in flare over time. GC cumulative dose substantially reduced. By Sho Fukui,MD,MPH. (Incoming BWH SCS postdoc) #ACR22
-
known US prevalence estimate of gout is based on a questionnaire study and overestimation has been discussed. @[email protected] used Bayesian Mia classification modeling to examine the impact. Within reasonable misclass parameter assumptions, corrected prev remained high! #ACR22
-
-
-
Last day of #ACR22 (for me)!
I called my kids to make sure they go to school. 4 yo was screaming in the background bc I woke him up
-
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future? - Liu - 2021 - Arthritis & Rheumatology - Wiley Online Library https://buff.ly/3UAImDd Looks like a useful review. Via #ACR22 JDM session
-
#ACR22 1809. Impact of Colchicine Prophylaxis on Cardiovascular Outcome Among Gout Patients: A Secondary Analysis of CARES Trial. No CV benefit with colchicine 6-month prophylaxis. Too short for this benefit? By Keigo Hayashi.
-
#ACR22 That Better Poster design would be great for this ignite talk format
-
#ACR22 0572. ACR Workgroup to Develop Recommendations for PRO Use in Clinical Care for SLE
Patricia Katz, PhD -
Worried about the Bird Site going down in flames and taking the #ACR22 content with it? It is archived here!
-
-
0550. Improving the Accuracy of Automated Gout Flare Ascertainment Using Natural Language Processing of Medical Records and Linked Medicare Claims Data for Real-world Comparative Effectiveness Research.
https://buff.ly/3OfRsmB I'll be presenting this later today #ACR22 -
Over Half of Methotrexate Users Reside in States in Which the Overturning of Roe v. Wade Can Jeopardize Access to Medications with Abortifacient Potential - Starzyk - Arthritis & Rheumatology - Wiley Online Library https://buff.ly/3fV5YmZ In time for #ACR22 @[email protected]
-
Some of my favorite speakers deliver content faster than I can type, and that pantheon includes @[email protected] & @[email protected] 😂
-
8 (!) arm RCT of supplements: SPORT
Bottom line: no supplement lowered LDL greater than PBO
-
What about CoQ10?
Statins ⬇️CoQ10 but no clear dose response
Small RCT: CoQ10 improved perception of sxs in pts with prior statin intolerance
Party line? May work, may not. Only harm is $
-
Clinical recs for statin intolerance?
💡Take away statin & wait & reassess
💡Try your own n of 1 with rechallengeIntolerance despite this? See cards guidelines
#ACR22 #Reviewcourse -
-
Quick points:
👉Ok to use statins in other neumomuscular disorders
👉Muscle bx for statin myopathy? Not needed. Esp don't do it if acute rhabdo
👉Check CK at statin start: No need
-
Another n of 1 statin trial, STATINWISE
👉didn't detect difference in muscle sxs between statin and pbo
Good data to decide if ok to restart/rechallenge statins!
Rechallenge does not apply to those with HMG-COA reductase Ab ❗️
-
SAMSON trial:
🔍nocebo effect (more sxs if you know you are on statin?)
🔍n of 1 trial (person serves as their own control)👉empty bottle, low sx severity score
👉no sx difference btw statin & pbo; but this was lower than if empty bottle -
What do we understand about exercise, statins, and CK?
We don't understand enough.